- Udyam number
- UDYAM-GJ-22-0101988

About Pharmarx India Private Limited
Data last updated:
Pharmarx India Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24294GJ2021PTC126080. Its GSTIN is 24AAMCP3598D1Z6 (Gujarat).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors Kishor Khimraj Tated and Falguniben Kishor Tated.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 140/2/A/1 GIDC, Ankleshwar, Gujarat, India – 393002.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.89 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹43.32 Lakh (net margin 1.7%) and EBITDA of ₹1.34 Cr (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 193% over three years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.22 Cr on record.
Pharmarx India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0101988). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmarxindia.com.
Company details
Recognitions & Rankings of Pharmarx India
Contact details
Pharmarx India Private Limited's registered office is in Ankleshwar, Gujarat. Its website is pharmarxindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. – 140/2/A/1 GIDC, Ankleshwar, Gujarat, India – 393002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pharmarx India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmarx India is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Pharmarx India Private Limited, buy the company report.
Financials of Pharmarx India Private Limited
FY 2025 filings availablePharmarx India Private Limited reported revenue of ₹25.89 Cr (up 61% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 193% over three years, including 61% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.34 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹43.32 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.2% | |||
| Net Profit Margin | 1.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Pharmarx India Private Limited, buy the company report.
Board of directors of Pharmarx India Private Limited
Pharmarx India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishor Khimraj Tated | Director | 04 Oct 2021 | 5 Years 1 Months | Current |
| Falguniben Kishor Tated | Director | 15 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Pharmarx India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Infer Radiological and Imaging Services Private Limited | ₹26.23 Cr (FY 2024) | 800.0% | Vijayawada, Andhra Pradesh, India | |||
| Sri Navodaya Institute of Medical Sciences Private Limited | ₹26.13 Cr (FY 2023) | -50.0% | Secunderabad, Telangana, India | |||
| Bionutriz Healthcare Private Limited | ₹26.06 Cr (FY 2024) | -21.0% | Bangalore, Karnataka, India | |||
| Dr. Muthus Hospital Private Limited | ₹26.01 Cr (FY 2025) | 46.0% | Coimbatore, Tamil Nadu, India | |||
| Akc Healthcare Private Limited | ₹25.97 Cr (FY 2025) | 35.0% | Nalgonda, Telangana, India | |||
| Pharmarx India Private Limitedthis company | ₹25.89 Cr (FY 2025) | ₹43.32 Lakh | 1.7% | 61.0% | 1 | Ankleshwar, Gujarat, India |
| Combined Medical Institute Private Limited | ₹25.74 Cr (FY 2025) | 4.0% | Haridwar Road Dehradun, Uttarakhand, India | |||
| Hexamed Technologies India Private Limited | ₹25.74 Cr (FY 2024) | 18.0% | Coimbatore, Tamil Nadu, India | |||
| Medivision Scan and Diagnostic Research Centre Pvt Ltd | ₹25.73 Cr (FY 2025) | 3.0% | Ernakulam, Kerala, India | |||
| Immuno Diagnostics Pvt Ltd | ₹25.65 Cr (FY 2024) | 12.0% | New Delhi, Delhi, India | |||
| Abhasa Wellness Retreat Private Limited | ₹25.49 Cr (FY 2025) | 15.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Pharmarx India Private Limited, buy the company report.
Auditor
Pharmarx India Private Limited is audited by V J R & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V J R & COMPANY | FY 2022 | 0154383W |
Shareholding
The shareholding of Pharmarx India Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Pharmarx India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2025 | 101060196 | Hdfc Bank Limited | ₹16 Lakh | Open | |
| 25 Apr 2024 | 100917202 | Others | ₹3 Cr | Open | |
| 28 Jan 2024 | 100882109 | Hdfc Bank Limited | ₹5.9 Lakh | Open |
To see the full charge records of Pharmarx India Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Pharmarx India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmarx India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmarx India Private Limited has a workforce of 1 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Pharmarx India Private Limited, buy the company report.
GST
Pharmarx India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAMCP3598D1Z6 | Gujarat | Active | 12 Jan 2022 |
To see the full GST registrations and return filing status of Pharmarx India Private Limited, buy the company report.
Recent activity
Pharmarx India Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Damjibhai Naranbhai Roy ceased to be Director on 15 Dec 2021.
Frequently asked questions
Pharmarx India is an active private limited company based in Ankleshwar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2021 (5+ years old) and is registered under CIN U24294GJ2021PTC126080.
Pharmarx India has 2 current directors:
- Kishor Khimraj Tated - Director
- Falguniben Kishor Tated - Director
The latest financial statements of Pharmarx India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Pharmarx India is 24AAMCP3598D1Z6, registered in Gujarat.
The CIN (Corporate Identification Number) of Pharmarx India is U24294GJ2021PTC126080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmarx India was incorporated on 04 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Pharmarx India by revenue are Infer Radiological and Imaging Services Private Limited, Sri Navodaya Institute of Medical Sciences Private Limited, Bionutriz Healthcare Private Limited, Dr. Muthus Hospital Private Limited, Akc Healthcare Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Damjibhai Naranbhai Roy ceased to be Director on 15 Dec 2021. Falguniben Kishor Tated was appointed as Director on 15 Dec 2021. Damjibhai Naranbhai Roy was appointed as Director on 04 Oct 2021. Pharmarx India has 4 board changes on record in total.
Yes, Pharmarx India is registered as an MSME under Udyam registration (number: UDYAM-GJ-22-0101988).
Pharmarx India can be reached through the website pharmarxindia.com. Its registered office is in Ankleshwar, Gujarat, India.
The registered office of Pharmarx India is at Plot No. – 1402A1 GIDC, Ankleshwar, Gujarat, India – 393002.

